NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market on Monday that its first-quarter revenues rose 7 percent while its net income jumped around 22 percent year over year.

The Hilden, Germany-based molecular diagnostics and sample preparation technologies firm reported total sales of $220.9 million for the three months ended March 31, compared to sales of $207.1 million for the first quarter of 2008. Foreign currency translation had a negative 9 percent effect on the first-quarter results while acquisitions added 5 percent to its revenue growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.